Clinical Trial Update: To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ELAD for severe acute alcoholic hepatitis with Lille score failure was terminated, and the study results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• ELAD (extracorporeal liver assist device)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Severe Acute Alcoholic Hepatitis | Phase 3 | Status: TERMINATED | Results posted: 2019-02-19